The European Commission has proposed giving Sweden €4.3 million to help 700 workers to find jobs after they were made redundant by drug-maker AstraZeneca.
Sweden applied for support from the European Globalisation Adjustment Fund to offset 987 jobs that were lost when AstraZeneca closed its R&D sites in Lund and Umeå, and cut down its activities in Mölndal and Södertälje.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.